The ASCENT project in Ethiopia
Ethiopia is one of the five countries where the ASCENT project is implemented. Over 80 health care facilities in the regions Addis Ababa and Oromia are participating in the project. Patient and health care workers will make use of digital adherence technologies to support patients taking their TB treatment at home. The first patients will be enrolled mid 2020. The project aims to reach 5,000 TB patients in Ethiopia in four years.
Ethiopia has a population of 109 million people and is one of the 30 high burden TB countries in the world, as listed by the World Health Organization (WHO). In 2018 an estimated 165,000 people suffered from TB in Ethiopia, making the TB incidence rate per 100,000 people 151. An estimated 1,600 people suffered from multidrug resistant TB. The WHO estimates 23,980 people died of TB in Ethiopia in 2018. At KNCV, we find this unacceptable as with the right treatment, TB can be cured. One of the goals of the ASCENT project is to increase the number of patients that complete their treatment successfully.

news & Stories from Ethiopia
How digital technologies can empower patients to succeed in TB treatment
The run-in phase of the ASCENT project has started, enrolling TB patients on digital adherence technologies in the Philippines and Ethiopia. Ukraine, Tanzania and South Africa will follow soon. With funding and support, Unitaid makes this project possible.
Budgeting tool for digital adherence technologies released
The ASCENT project releases a free Total Cost of Ownership (TCO) Tool, to enable accurate budget forecasting for the implementation and use of Digital Adherence Technologies (DATs) in TB treatment.
Smart medication container included in GDF product catalog
The Stop TB Partnership and the ASCENT project are proud to announce the introduction of an easy and efficient way to procure digital adherence technologies.
The Community Advisory Board for the ASCENT project is established
The Community Advisory Board (CAB) for the ASCENT project in Ethiopia was established to guard the safety and well-being of beneficiaries/study participants.